SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CTEC: Cholestech any other investors?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Duane L. Olson who wrote (474)4/2/1998 1:58:00 PM
From: Turs  Read Replies (1) of 710
 
Just got a copy of the NewsWeek article and read it. Actually, if this test catches on, it would seemingly reduce the need for cholesterol screening, since they are both targeting the same thing: early indication of heart problems. But apparently, this CT Scan can detect any trouble earlier than can a cholesterol reading and in some cases, your cholesterol may look normal, but your arteries may still be calcified, putting you at risk for a heart attack, and only the CT Scan would indicate this. This new test is noninvasive, which is good, but it does cost $350-500 vs. a $20 test from Cholestech. What I could see happening is that you are initially screened with the CT Scan. Then you are put on a diet and exercise regimen and monitored every 3-6 months for your cholesterol levels with an LDX from Cholestech. Phil-does that sound like what would happen in reality?

We'll also have to see if insurance companies eventually pay for it (they don't now). It's definitely something to keep an eye on.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News